ClinConnect ClinConnect Logo
Search / Trial NCT06030531

Spasticity and Functional Recovery After SCI

Launched by SHIRLEY RYAN ABILITYLAB · Sep 1, 2023

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Spasticity Recovery Bio Markers

ClinConnect Summary

The purpose of this study is to measure changes to motor-evoked potentials (MEPs) and to evaluate if the development of spasticity is related to residual descending motor pathways and to a better neurological recovery and functional improvement in individuals with SCI from the acute to the subacute phase. The investigators will also test for the presence of biological markers in the blood that may correlate with levels of spasticity or neurological recovery and functional improvement, including the presence or absence of neuroplastic genetic polymorphisms (e.g. BDNF Val66Met polymorphism), ...

Gender

ALL

Eligibility criteria

  • Individuals with SCI:
  • Inclusion criteria:
  • Male and females 18 years of age or greater
  • Basic proficiency in English language communication
  • Are admitted to the Shirley Ryan AbilityLab as a spinal cord injury patient
  • International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) level above L2
  • American Spinal Cord Injury Association Impairment Scale (AIS) grades A, B, C, or D
  • Patients with SCI within the first week of inpatient admission to the Shirley Ryan AbilityLab after sustaining a SC
  • Exclusion criteria:
  • Under 18 years of age
  • Severe cognitive impairment that precludes the ability to participate in a comprehensive physical exam or give verbal consent
  • ISNCSCI level below L2
  • People who have sustained SCI \>30 days
  • Uncontrolled medical problems including pulmonary, cardiovascular or orthopedic disease
  • Any debilitating disease prior to the SCI that caused exercise intolerance
  • Premorbid, ongoing major depression or psychosis, altered cognitive status
  • History of head injury or stroke
  • Vascular, traumatic, tumoral, infectious, or metabolic lesion of the brain, even without history of seizure, and without anticonvulsant medication
  • History of seizures or epilepsy
  • Ongoing cord compression or a syrinx in the spinal cord or people who suffer from a spinal cord disease such as spinal stenosis, spina bifida, MS, or herniated disk 13. Metal plate in skull
  • Individuals with scalp shrapnel, cochlear implants, or aneurysm clips
  • Skull fractures, skull deficits or concussion within the last 6 months
  • Presence of orthoses and presence of spinal precautions or healing incisions that make the area inaccessible to the testing procedures. This criterion will be applied as needed for the specific study procedures that may need to access the areas under restriction.
  • Formal diagnosis of Post-Traumatic Stress Disorder (PTSD)
  • Individuals in the control group:
  • Inclusion criteria:
  • 1. Male and females 18 years of age or greater
  • 2. Basic proficiency in English language communication
  • Exclusion criteria:
  • 1. Under 18 years of age
  • 2. Uncontrolled medical problems including pulmonary, cardiovascular, or orthopedic disease
  • 3. History of neurological impairment or conditions affecting the Central Nervous System
  • 4. Premorbid, ongoing major depression or psychosis, altered cognitive status
  • 5. Pregnancy

About Shirley Ryan Abilitylab

Shirley Ryan AbilityLab is a leading research and rehabilitation institute dedicated to advancing the science of physical medicine and rehabilitation. Based in Chicago, Illinois, the organization integrates clinical care, research, and education to enhance the quality of life for individuals with disabilities and chronic conditions. Known for its innovative approach, Shirley Ryan AbilityLab conducts clinical trials that aim to develop and evaluate cutting-edge therapies and technologies, fostering a collaborative environment that bridges the gap between laboratory research and patient care. Through its commitment to excellence, the institute strives to empower patients and improve outcomes in rehabilitation medicine.

Locations

Chicago, Illinois, United States

Patients applied

0 patients applied

Trial Officials

Monica A Perez, PT, PhD

Principal Investigator

Shirley Ryan AbilityLab

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported